Kevin F. Mclaughlin - 10 Oct 2022 Form 3 Insider Report for Decibel Therapeutics, Inc.

Role: Director
Signature: Jeffrey W. Schulz, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 10 Oct 2022
Net transactions value: $0
Form type: 3
Filing time: 12 Oct 2022, 08:13:27 UTC
Previous filing: 29 Apr 2022
Next filing: 28 Apr 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney